Provider
The telehealth service is expanding across Asia two years since its launch in Singapore.
A study published in JAMA Network Open found CCBT led to improved depressive symptoms in primary care patients compared with treatment as usual alone.
The continuous glucose monitoring system can be used to measure glucose levels in adults with diabetes for up to six months.
The feature will be introduced in the second quarter of the year.
Precision genomics could impact the payer, provider and life science space.
HIMSS22
In a preview of their HIMSS22 session, Serena Bumpus of Ascension and Stephanie Hoelscher of the Texas Tech University Health Sciences Center explain their Texas pilot study on crisis documentation during COVID-19 surges and how it could lessen the burden on nurses.
Also, HCA Healthcare UK opens £26M specialist oncology unit at UCLH.
Also, Genesis MedTech has acquired Chinese valve replacement device maker JC Medical.
The acquisition will cost $53.5 million in cash, plus an earnout consideration of up to $24 million and around $5 million in stock to employees joining Doximity.
The website will go online on 12 February.